Abstract:Abstract Background Cell proliferation and death are key components of wound healing and tissue repair. Telocytes (TCs) represent a newly discovered cell type that can protect tissue from acute injury via cell–cell communication with adjacent cells. The aim of this study was to use a mouse model of skin wound healing and lipopolysaccharide (LPS)-induced cell injury to evaluate the effects of TCs on skin wound healing in vivo and in vitro. Material/methods Immunohistochemical staining was performed to evaluate the alteration of TCs in tissues from normal and chronic wound patients. Then, a male C57BL/6 mouse wound model of the back was established. The mice were divided randomly into three groups, and wound healing was estimated according to the wound healing rate and histology. An LPS-induced co-culture model of a mouse lung telocyte cell line (TCs) with human keratinocyte (HaCaT), human dermal microvascular endothelial cell (HDMEC) or murine fibroblast (L929) cell lines was established to analyse the effects of TCs on constitutive cell types of the skin. Cell proliferation, migration and apoptosis were examined, and reactive oxygen species (ROS) and inflammatory factors in HaCaT cells, HDMECs, and L929 cells were detected to study the mechanisms involved in TC protection in skin wounds. Results TCs were significantly increased in tissues from chronic wound patients compared with healthy controls. Wound healing was significantly improved in wound mouse models treated with exogenous TCs compared with LPS-induced models. TCs reversed the LPS-induced inhibition of HaCaT cells and HDMECs and reduced the LPS-induced apoptosis of HaCaT cells and the death ratios of HDMECs and L929 cells. TCs reversed LPS-induced ROS in HDMECs and L929 cells and decreased inflammatory factor mRNA levels in HaCaT cells, HDMECs and L929 cells. Conclusions TCs reduce wound healing delay, and inflammatory responses caused by LPS might be mediated by inflammatory inhibition, thus restricting apoptosis and promoting migration of the main component cell types in the skin.

Aberrant Wound Healing in an Epidermal Interleukin-4 Transgenic Mouse Model of Atopic Dermatitis

Diminished γδ T Cells during allergic skin inflammation is mediated by IL-4 signaling in keratinocytes

MicroRNA-34a deficiency leads to impaired wound closure by augmented inflammation in mice

IL-36 receptor antagonist deficiency resulted in delayed wound healing due to excessive recruitment of immune cells

IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing

Vγ4 T Cells Inhibit the Pro-healing Functions of Dendritic Epidermal T Cells to Delay Skin Wound Closure Through IL-17A

Cutting Edge: Regulatory T Cells Facilitate Cutaneous Wound Healing

Functions of Vγ4 T Cells and Dendritic Epidermal T Cells on Skin Wound Healing

Abnormal IL-4 Gene Expression by Atopic Dermatitis T Lymphocytes is Reflected in Altered Nuclear Protein Interactions with IL-4 Transcriptional Regulatory Element

Keratinocyte Integrin α3β1 Promotes Efficient Healing of Wound Epidermis

TGFβ-mediated inhibition of hypodermal adipocyte progenitor differentiation promotes wound-induced skin fibrosis

Wound-healing defect of CD18−/− mice due to a decrease in TGF-β1 and myofibroblast differentiation

Single-cell analysis of skin immune cells reveals an Angptl4-ifi20b axis that regulates monocyte differentiation during wound healing

IL-17 in wound repair: bridging acute and chronic responses

Cutaneous Wounds in Mice Lacking TSG-6 Exhibit Delayed Closure and an Abnormal Inflammatory Response

Defects in Dermal Vγ4 Γ Δ T Cells Result in Delayed Wound Healing in Diabetic Mice.

Characterization of Smad3 knockout mouse derived skin cells

Local Administration of Interleukin-1 Receptor Antagonist Improves Diabetic Wound Healing

Role Of Tgf Beta-Mediated Inflammation In Cutaneous Wound Healing

Telocytes inhibited inflammatory factor expression and enhanced cell migration in LPS-induced skin wound healing models in vitro and in vivo

1463 Keratinocyte Autophagy Regulates Wound Healing Through MCP-1-mediated Keratinocyte Migration and Fibroblast Activation